Cyclacel Pharmaceuticals, Inc. to Announce Release of First Quarter 2013 Financial Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BERKELEY HEIGHTS, N.J., May 10, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders will announce first quarter 2013 financial results on Monday, May 13, 2013. The Company will host a conference call and live webcast at 4:30 pm Eastern time on the same day.
Help employers find you! Check out all the jobs and post your resume.
BERKELEY HEIGHTS, N.J., May 10, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders will announce first quarter 2013 financial results on Monday, May 13, 2013. The Company will host a conference call and live webcast at 4:30 pm Eastern time on the same day.
Help employers find you! Check out all the jobs and post your resume.